A gut-targeted small molecule therapeutic designed to reduce irritability and other symptoms associated with Autism Spectrum Disorder by sequestering specific bacterial metabolites in the gut.

A gut-restricted small molecule amyloid inhibitor in preclinical development aimed at treating Parkinson’s Disease by reducing bacterial amyloid aggregation in the gut to alleviate symptoms and modify disease progression.